1 results match your criteria: "The Second Affiliated Hospital of Nanjing Medical University Nanjing 210009 China symaoxinyu@163.com zhangyewei@njmu.edu.cn.[Affiliation]"
Nanotechnology strategies for hepatocellular carcinoma diagnosis and treatment.
RSC Adv
October 2022
Hepatopancreatobiliary Center, The Second Affiliated Hospital of Nanjing Medical University Nanjing 210009 China
Hepatocellular carcinoma (HCC) is a common malignancy threatening human health, and existing diagnostic and therapeutic techniques are facing great challenges. In the last decade or so, nanotechnology has been developed and improved for tumor diagnosis and treatment. For example, nano-intravenous injections have been approved for malignant perivascular epithelioid cell tumors.
View Article and Find Full Text PDF